Literature DB >> 18580528

Intestinal trefoil factor produced in Escherichia coli promotes the healing of rat burn-induced acute gastric mucosal lesions.

Yong Sun1, Wei Wu, Yong Zhang, Shangjun Lv, Shiliang Wang, Xi Peng.   

Abstract

BACKGROUND: Intestinal trefoil factor (ITF), a member of the trefoil factor family, plays an important role in protecting the epithelial layer of the gastrointestinal tract from damage and repairing epithelium after injury. This study aims to produce ITF by Escherichia coli expression system and explore its role in the treatment of burn-induced acute gastric mucosal lesions.
METHODS: Human ITF (hITF) gene encoding mature peptide was obtained by RT-PCR, and then inserted into the expression vector pET32a to construct the recombinant pET32a-hITF. After confirmation by gene sequencing, pET32a-hITF was transformed into E. coli Origami B(DE3), and TrxA-hITF fusion protein was expressed by conventional isopropyl-beta-d-thiogalactopyranoside induction in shake flask and analyzed with sodium dodecyl sulfate-polyacrylamide gel electorphoresis (SDS-PAGE) and Western-blot. Subsequently, TrxA-hITF was isolated by Nickel-nitrilotriacetic acid affinity chromatography, and ultrafiltration. Finally, a burn-induced rat gastric injury model was established, TrxA-hITF was administered orally and macroscopic and microscopic changes in gastric mucosa were observed.
RESULTS: The correctness and integrity of hITF gene were identified by restriction digestion and gene sequencing. TrxA-hITF fusion protein was successfully expressed to 50 mg/L and its purity was above 95% after purification. SDS-PAGE and Western-blot analyses showed that the fusion protein presented as a single band with a molecular weight of 32 kDa, a little larger than the calculated value, 30 kDa. Lesion score and histologic examination revealed that TrxA-hITF alleviated rat gastric injury significantly.
CONCLUSIONS: This study lays foundation for the commercial production of hITF and suggests a new way to treat burn-induced gastric lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18580528     DOI: 10.1097/TA.0b013e318076b49f

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  4 in total

Review 1.  Can we protect the gut in critical illness? The role of growth factors and other novel approaches.

Authors:  Jessica A Dominguez; Craig M Coopersmith
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

Review 2.  The progress of Chinese burn medicine from the Third Military Medical University-in memory of its pioneer, Professor Li Ao.

Authors:  Haisheng Li; Junyi Zhou; Yizhi Peng; Jiaping Zhang; Xi Peng; Qizhi Luo; Zhiqiang Yuan; Hong Yan; Daizhi Peng; Weifeng He; Fengjun Wang; Guangping Liang; Yuesheng Huang; Jun Wu; Gaoxing Luo
Journal:  Burns Trauma       Date:  2017-05-30

3.  Recombinant adenovirus-mediated intestinal trefoil factor gene therapy for burn-induced intestinal mucosal injury.

Authors:  Yong Sun; Yun Zhu; Liangxi Wang; Xuefei Mao; Xi Peng; Yizhi Peng
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

4.  Cloning and characterization of the human trefoil factor 3 gene promoter.

Authors:  Yong Sun; Liangxi Wang; Yifang Zhou; Xuefei Mao; Xiangdong Deng
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.